AAAAAA

   
Results: 1-9 |
Results: 9
The psychoactive ingredient of marijuana induces behavioural sensitization
Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., The psychoactive ingredient of marijuana induces behavioural sensitization, EUR J NEURO, 14(5), 2001, pp. 884-886
Cannabinoids inhibit nitric oxide production in bone marrow derived felinemacrophages
Authors: Ponti, W Rubino, T Bardotti, M Poli, G Parolaro, D
Citation: W. Ponti et al., Cannabinoids inhibit nitric oxide production in bone marrow derived felinemacrophages, VET IMMUNOL, 82(3-4), 2001, pp. 203-214
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments
Authors: Rubino, T Vigano, D Zagato, E Sala, M Parolaro, D
Citation: T. Rubino et al., In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments, SYNAPSE, 35(1), 2000, pp. 8-14
Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions
Authors: Rubino, T Vigano, D Massi, P Spinello, M Zagato, E Giagnoni, G Parolaro, D
Citation: T. Rubino et al., Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions, NEUROPHARM, 39(7), 2000, pp. 1331-1336
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome
Authors: Rubino, T Massi, P Vigano, D Fuzio, D Parolaro, D
Citation: T. Rubino et al., Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome, LIFE SCI, 66(22), 2000, pp. 2213-2219
Loss of cannabinoid-stimulated guanosine 5 '-O-(3-[S-35]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats
Authors: Rubino, T Vigano, D Costa, B Colleoni, M Parolaro, D
Citation: T. Rubino et al., Loss of cannabinoid-stimulated guanosine 5 '-O-(3-[S-35]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats, J NEUROCHEM, 75(6), 2000, pp. 2478-2484
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940
Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940, J NEUROCHEM, 75(5), 2000, pp. 2080-2086
Presence of a reduced opioid response in interleukin-6 knock out mice
Authors: Bianchi, M Maggi, R Pimpinelli, F Rubino, T Parolaro, D Poli, V Ciliberto, G Panerai, AE Sacerdote, P
Citation: M. Bianchi et al., Presence of a reduced opioid response in interleukin-6 knock out mice, EUR J NEURO, 11(5), 1999, pp. 1501-1507
Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters
Authors: Massi, P Sacerdote, P Ponti, W Fuzio, D Manfredi, B Vigano, D Rubino, T Bardotti, M Parolaro, D
Citation: P. Massi et al., Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters, J NEUROIMM, 92(1-2), 1998, pp. 60-66
Risultati: 1-9 |